Clobazam: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Clobazam. Educational only — not medical advice.
Labeled uses
Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Source: FDA labeling via NIH DailyMed (set 4b92ac57…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.